This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Hari Krishna Namballa
Introduction
Hari Krishna Namballa is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of potential anticancer agents. His work is characterized by a strong focus on innovative compounds that can combat human cancer cell lines.
Latest Patents
Namballa holds a patent for a compound titled "N-((1-phenyl-9H-pyrido[3,4-b]indol-3-yl)methyl)cinnamamides as potential anticancer agents and preparation thereof." This patent describes a compound of general formula A, which is useful as a potential anticancer agent. The compound is designed to target various human cancer cell lines, showcasing its potential in cancer treatment. The general formula A includes various substituents such as R=3-F, 3,4,5-OMe, 4-OMe, H, 4-CF, 4-Cl, and others, indicating a diverse range of chemical modifications that enhance its efficacy.
Career Highlights
Hari Krishna Namballa is affiliated with the Council of Scientific and Industrial Research, where he engages in cutting-edge research and development. His work has led to advancements in the field of cancer therapeutics, contributing to the scientific community's understanding of potential treatment options.
Collaborations
Namballa collaborates with esteemed colleagues such as Nagesh Narayana and Ahmed Kamal. These partnerships enhance the research environment and foster innovation in their respective fields.
Conclusion
In summary, Hari Krishna Namballa is a prominent inventor whose work in developing anticancer agents has the potential to make a significant impact in the medical field. His innovative approach and dedication to research exemplify the spirit of scientific inquiry and advancement.